Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on March 30, 2007
Chest, doi:10.1378/chest.06-1999
doi:10.1378/chest.06-1999
(Chest. 2007; 132:396-402)
© 2007 American College of Chest Physicians
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
chest.06-1999v1
132/2/396    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, R. L.
Right arrow Articles by Crapo, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, R. L.
Right arrow Articles by Crapo, R. O.
Related Content
Right arrowRelated Article
Right arrowRelated Editorial

Sources of Long-term Variability in Measurements of Lung Function*

Implications for Interpretation and Clinical Trial Design

Robert L. Jensen, PhD; John G. Teeter, MD; Richard D. England, MD, PhD; Heather M. Howell; Heather J. White, DVM; Eve H. Pickering, PhD and Robert O. Crapo, MD, FCCP

* From LDS Hospital and University of Utah (Drs. Jensen and Crapo, and Ms. Howell), Salt Lake City, UT; and Pfizer Global Research and Development (Drs. Teeter, England, White, and Pickering), Groton, CT.

Correspondence to: Robert L. Jensen, PhD, Pulmonary Laboratory, LDS Hospital and University of Utah, Eighth Ave and C St, Salt Lake City, UT 84143; e-mail: ldrjens1{at}ihc.com

Abstract

Background: The objective of the study was to characterize the biological and technical components of variability associated with longitudinal measurements of FEV1 and carbon monoxide diffusing capacity (DLCO). Variability was apportioned to subject and instrument for five commercially available pulmonary function testing (PFT) systems: Collins CPL (Ferraris Respiratory; Louisville, CO); Morgan Transflow Test PFT System (Morgan Scientific; Haverhill, MA); SensorMedics Vmax 22D (VIASYS Healthcare; Yorba Linda, CA); Jaeger USA Masterscreen Diffusion TP (VIASYS Healthcare; Yorba Linda, CA); and Medical Graphics Profiler DX System (Medical Graphics Corporation; St. Paul, MN).

Methods: This was a randomized, replicated cross-over, single-center methodology study in 11 healthy subjects aged 20 to 65 years. Spirometry and DLCO measurements were performed at baseline, 3 months, and 6 months. Repetitive simulations of FEV1 and DLCO were performed on the same instruments on four occasions over a 90-day period using a spirometry waveform generator and a DLCO simulator.

Results: The coefficient of variation associated with repetitive measurements of FEV1 or DLCO in subjects was consistently larger than that associated with repetitive simulated waveforms across the five instruments. Instrumentation accounted for 13 to 58% of the total FEV1 and 36 to 70% of the total DLCO variability observed in subjects. Sample size estimates of hypothetical studies designed to detect treatment group differences of 0.050 L in FEV1 and 0.5 mL/min/mm Hg in DLCO varied as much as four times depending on the instrument utilized.

Conclusions: These results provide a semiquantitative assessment of the biological and technical components of PFT variability in a highly standardized setting. They illustrate how instrument choice and test variability can impact sample size determinations in clinical studies that use FEV1 and DLCO as end points.

Key Words: clinical trial design • diffusing capacity • diffusing capacity simulator • pulmonary function testing • pulmonary waveform generator • spirometry • variability


Related Article

Instrument Accuracy and Reproducibility in Measurements of Pulmonary Function
Robert L. Jensen, John G. Teeter, Richard D. England, Heather J. White, Eve H. Pickering, and Robert O. Crapo
Chest 2007 132: 388-395. [Abstract] [Full Text] [PDF]

Related Editorial

Finding Signals Amidst the Noise in Pulmonary Function Testing
Neil MacIntyre
Chest 2007 132: 367-368. [Full Text] [PDF]



This article has been cited by other articles:


Home page
ChestHome page
N. MacIntyre
Finding Signals Amidst the Noise in Pulmonary Function Testing
Chest, August 1, 2007; 132(2): 367 - 368.
[Full Text] [PDF]


Home page
ChestHome page
R. L. Jensen, J. G. Teeter, R. D. England, H. J. White, E. H. Pickering, and R. O. Crapo
Instrument Accuracy and Reproducibility in Measurements of Pulmonary Function
Chest, August 1, 2007; 132(2): 388 - 395.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.